IL6 and Insulin resistance: Each of these models exhibits insulin resistance and impaired glucose metabolism, which was demonstrated by a glucose tolerance test (GTT) and insulin tolerance test (ITT), and systemic inflammation characterized by elevated plasma IL-6 [11] and TNF-α [95] levels.